Filter News
Area of Research
News Topics
- (-) Advanced Reactors (1)
- (-) Biomedical (6)
- 3-D Printing/Advanced Manufacturing (1)
- Artificial Intelligence (9)
- Big Data (2)
- Bioenergy (2)
- Biology (6)
- Buildings (3)
- Chemical Sciences (3)
- Climate Change (7)
- Computer Science (30)
- Coronavirus (5)
- Critical Materials (2)
- Cybersecurity (3)
- Decarbonization (1)
- Energy Storage (4)
- Environment (8)
- Exascale Computing (5)
- Frontier (9)
- Grid (1)
- High-Performance Computing (16)
- Isotopes (2)
- Machine Learning (5)
- Materials (7)
- Materials Science (8)
- Microscopy (4)
- Molten Salt (3)
- Nanotechnology (4)
- National Security (4)
- Neutron Science (4)
- Nuclear Energy (5)
- Partnerships (1)
- Physics (3)
- Polymers (1)
- Quantum Computing (12)
- Quantum Science (8)
- Security (3)
- Simulation (4)
- Space Exploration (1)
- Summit (13)
- Sustainable Energy (2)
- Transportation (2)
Media Contacts
ORNL scientists will present new technologies available for licensing during the annual Technology Innovation Showcase. The event is 9 a.m. to 3 p.m. Thursday, June 16, at the Manufacturing Demonstration Facility at ORNL’s Hardin Valley campus.
A team of researchers has developed a novel, machine learning–based technique to explore and identify relationships among medical concepts using electronic health record data across multiple healthcare providers.
University of Pennsylvania researchers called on computational systems biology expertise at Oak Ridge National Laboratory to analyze large datasets of single-cell RNA sequencing from skin samples afflicted with atopic dermatitis.
To explore the inner workings of severe acute respiratory syndrome coronavirus 2, or SARS-CoV-2, researchers from ORNL developed a novel technique.
An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.
The Department of Energy’s Oak Ridge National Laboratory is collaborating with industry on six new projects focused on advancing commercial nuclear energy technologies that offer potential improvements to current nuclear reactors and move new reactor designs closer to deployment.
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.